Abstract
The aim of the present study is to develop cross-linked chitosan (CH) films that can release drug over an extended period of time and that too in a controlled manner. A solution of different percentages of CH, is prepared in 1% lactic acid, followed by addition of citalopram (CTP) and then reacted with increasing amounts of glutaraldehyde (GL) to obtain films with different cross-linking densities. Prepared films are characterized for their physical and mechanical properties. The films are then subjected to in vitro drug release studies using pH 7·4 phosphate buffer saline (PBS) as dissolution medium and cumulative amount of drug released is calculated. Kinetic analysis of drug release is performed using Power law model and Higuchi’s model. With increase in concentration of CH, water absorption capacity and mechanical strength are increased; whereas, water vapour permeability and elasticity of the films are decreased. The effect of cross-linking agent, GL, is such that with an increase in the amount of GL, water vapour permeability, water absorption capacity and elasticity of the films are decreased; whereas, mechanical strength increased to some extent and then decreased. In vitro release studies indicate that films containing 3% CH, cross-linked with 2–3% GL and films containing 4% CH, cross-linked 1% GL are able to sustain the drug release for a prolonged time along with releasing almost complete drug in a desired period. Out of these batches, films containing 3% CH, cross-linked with 2–3% GL are having sufficient strength, water vapour permeation, water absorption capacity and elongation at break for implantation purpose. The in vitro degradation studies and histopathological studies were carried out with a sample film (batch C3 as in table 1) in rabbit model. In vitro degradation study indicates that the films maintained their integrity for desired implantation. The histopathological studies under optical microscope indicates that on implanting, there is no evidence of any inflammation, any foreign body granuloma or any necrosis or hemorrhage. Tissue configuration remains unaltered after 30 days of implantation. So, it can be suggested that cross-linked CH films of above said composition can be used as implant for long term application in depression and related disorders.
Similar content being viewed by others
References
Adriano W S, Filho E H C, Silva J A and Goncalves L R B 2005 Biotech. Appl. Biochem. 41201
Andrews J M and Nemeroff C B 1994 Am. J. Med. 9724S
Arvanitoyannis I, Nakayama A and Aiba S 1998 Carbohydr. Polym. 37371
Bayramocglu G, Yylmaz M and Aryca M Y 2003 Biochem. Eng. J. 1335
Beppu M M, Arruda E J, Vieira R S and Santos N N 2004 J. Membr. Sci. 240 227
Beppu M M, Vieira R S, Aimoli C G and Santana C C 2007 J. Membr. Sci. 301 126
Blanco M D, Gomez C and Olmo R 2000 Int. J. Pharm. 202 29
Crini G 2006 Bioresour. Technol. 971061
David P, Manssur Y and Mark S 1992 Carbohydr. Res. 237 325
Frazer A 1997 J. Clin. Psychiat. 589
Genta I, Constantini M, Asti A, Conti B and Montanari L 1998 Carbohydr. Polym. 3681
Gliko-Kabir B, Yagen A, Penhasi A and Rubinstein A 2000 J. Control. Rel. 63121
Guibal E 2004 Sep. Purif. Technol. 3843
Gupta K C and Kumar M N V R 2000 Biomaterials 201115
Higuchi T 1963 J. Pharm. Sci. 521145
Jameela S R and Jayakrishnan A 1995 Biomaterials 16769
Jameela S R, Misra A and Jayakrishnan A 1994 J. Biomater. Sci. Polym. Edn. 6 621
Jameela S R, Kumary Y V, Lal A V and Jayakrishnan A 1998 J. Control Rel. 5217
Kalapathy U, Proctor A and Shultz J 2000 Bioresour. Technol. 7299
Korsmeyer R W, Gurny R, Doelker E, Buri P and Peppas N A 1983 J. Pharm. Sci. 72 1189
Miao Y Q and Tan S N 2000 Analyst 125 1591
Mi F L, Shyu S S and Wu Y B 2001 Biomaterials 22165
Miyazaki S, Ishii K and Nadai T 1981 Chem. Pharm. Bull. 293067
Muzzarelli R A 1993 Carbohydr. Polym. 207
Ngah W S W, Endud C S and Mayanar R 2002 React. Funct. Polym. 50181
Preskorn S H 1995 J. Clin. Psychiat. 5612
Remunan-Lopez C and Bodmeier R 1997 J. Control. Rel. 44215
Rickels K and Schweizer E 1990 J. Clin. Psychiat. 519
Sezer A G, Hatipoglu F, Cevher E, Oğurtan Z, Bas A L and Akbuğa J 2007 AAPS PharmSciTech. 8 E94
Shu X Z, Zhu K J and Weihong S 2001 Int. J. Pharm. 212 19
Thomas C and Sharma P 1990 Biomater. Artif. Cells Artif. Org. 181
Tomihata K and Ikada Y 1997 Biomaterials 18567
Vieira R S and Beppu M M 2005 Adsorption – J. Int. Ads. Soc. 11731
Vieira R S and Beppu M M 2006 Water Res. 401726
Wang L Y, Ma G H and Su Z G 2005 J. Control. Rel. 106 62
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
KUNDU, P.P., JINDAL, S.K. & GOSWAMI, M. Characterization and in vitro and in vivo evaluation of cross-linked chitosan films as implant for controlled release of citalopram. Bull Mater Sci 36, 175–182 (2013). https://doi.org/10.1007/s12034-013-0425-8
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12034-013-0425-8